Ablation of bone cells by electroporation

Abstract

Short intense electrical pulses transiently increase the permeability of the cell membrane, an effect known as electroporation. This can be combined with antiblastic drugs for ablation of tumours of the skin and subcutaneous tissue. The aim of this study was to test the efficacy of electroporation when applied to bone and to understand whether the presence of mineralised trabeculae would affect the capability of the electric field to porate the membrane of bone cells. Different levels of electrical field were applied to the femoral bone of rabbits. The field distribution and modelling were simulated by computer. Specimens of bone from treated and control rabbits were obtained for histology, histomorphometry and biomechanical testing. After seven days, the area of ablation had increased in line with the number of pulses and/or with the amplitude of the electrical field applied. The osteogenic activity in the ablated area had recovered by 30 days. Biomechanical testing showed structural integrity of the bone at both times. Electroporation using the appropriate combination of voltage and pulses induced ablation of bone cells without affecting the recovery of osteogenic activity. It can be an effective treatment in bone and when used in combination with drugs, an option for the treatment of metastases.

Preclinical Validation of Electrochemotherapy as an Effective Treatment for Brain Tumors

“…Electroporation-based treatments in internal organs are ongoing (www.clinicaltrials.gov; refs. 26,27).…”

Electrochemotherapy to Metastatic Spinal Melanoma

“…The results of this study show that electroporation can induce ablation of bone cells without affecting the recovery of osteogenic activity. 8,9 Based on this study A 51-year-old female Caucasian patient presented 4 successive occurrences of epistaxis. Nasal examination revealed a polypoid mass lesion of right nasal cavity originating from the inferior concha.…”

Drug and Gene Electrotransfer in Cancer Therapy

“…Whereas only a few centers were active in 2006, when standard operating procedures were first published , today over 100 centers are offering electrochemotherapy in Europe alone. The electrochemotherapy concept is now being taken to internal organs as well, notably clinical trials on the liver (Edhemovic et al 2011); bone (Fini et al 2010), clinical trial ongoing; brain (Linnert and Gehl 2009;Agerholm-Larsen et al 2011;Linnert et al 2012), and colorectal cancer as described in review by Miklavcic et al (2012).…”